BioCryst Pharmaceuticals, Inc. - BCRX

SEC FilingsOur BCRX Tweets

About Gravity Analytica

Recent News

  • 09.04.2025 - Cantor Global Healthcare Conference
  • 09.04.2025 - Cantor Global Healthcare Conference
  • 09.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 09.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 09.03.2025 - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 08.21.2025 - BioCryst to Present at Upcoming Investor Conference
  • 08.21.2025 - BioCryst to Present at Upcoming Investor Conference
  • 08.21.2025 - BioCryst to Present at Upcoming Investor Conference
  • 08.11.2025 - BioCryst Announces Departure of Dr. Helen Thackray
  • 08.11.2025 - BioCryst Announces Departure of Dr. Helen Thackray

Recent Filings

  • 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.15.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.13.2025 - 144 Report of proposed sale of securities
  • 08.12.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 08.11.2025 - 8-K Current report